Palo Alto Networks, Inc. (PANW) Unveils Seven AI-Driven Cybersecurity Predictions for 2025
We recently compiled a list of the 10 AI News Making Waves Today. In this article, we are going to take a look at where Palo ...
Palo Alto Networks price target raised to $425 from $385 at Baird
Baird raised the firm’s price target on Palo Alto Networks (PANW) to $425 from $385 and keeps an Outperform rating on the shares. The ...
Palo Alto Networks warns of critical RCE zero-day exploited in attacks
Palo Alto Networks is warning that a critical zero-day vulnerability on Next-Generation Firewalls (NGFW) management ...
SecurityWeek1d
Palo Alto Networks Confirms New Firewall Zero-Day Exploitation
Palo Alto Networks confirmed that a zero-day is being exploited in attacks after investigating claims of a firewall remote ...
Palo Alto Weekly1d
Palo Alto council race may be heading for a recount
Palo Alto voters may not know the full results of the City Council race until early December, with the contest between ...
CISA warns of more Palo Alto Networks bugs exploited in attacks
CISA warned today that two more critical security vulnerabilities in Palo Alto Networks' Expedition migration tool are now ...
Barchart on MSN1d
Palo Alto Networks Stock Outlook: Is Wall Street Bullish or Bearish?
With a market cap of $131 billion, Santa Clara, California-based Palo Alto Networks, Inc. (PANW) provides comprehensive ...
Palo Alto Networks: Transforming Cybersecurity Through Platformization, Buy
Palo Alto Networks has made a bold shift to accelerate platformization. Read why it may hurt short term but has excellent ...
Palo Alto Weekly2d
To meet climate change goals, Palo Alto redoubles electrification efforts
After years of steady progress, Palo Alto took an unwelcome detour on its path toward carbon neutrality in 2022, when the ...
Kriya Announces Publication of Preclinical Data for its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis
Results demonstrate statistically significant fibrosis reversal and protection against hepatocellular carcinoma in animal models of MASH – – Kriya plans to evaluate KRIYA-497, a one-time intramuscular ...